FDA MoCRA biennial renewal opens; product listings >1M, adverse events up 3x

February 2026 — FDA cosmetic facility registration biennial renewal cycle opened for brands that registered in February 2024; July 2024 registrants face renewal by mid-2026. Post-MoCRA, FDA's registered facility count grew from 5,176 (pre-law voluntary) to 15,000 active facilities, and product listings from 35,102 to over 1 million. Adverse-event reports from industry rose more than 3x. Safety substantiation has been enforceable since December 2023 via mandatory recall authority. The fragrance-allergen labelling NPRM (RIN 0910-AI90) is on a May 2026 target date — would require individual allergen disclosure and end compound bundling under 'fragrance.'

Source

FDA / In My Kit

FDA MoCRA biennial renewal opens; product listings >1M, adverse events up 3x

EU Directive 2024/825 anti-greenwashing rules apply Sept 27, 2026 — no grandfathering confirmed

ASA upholds claims complaint against 111 Skin — narrow ruling, not a new enforcement wave

UK APPG on Beauty calls for VAT cut on sunscreen in 'Preventable Crisis' report

EU Omnibus VIII in force May 1; 82-allergen disclosure rule binds July 31 — no grace period